These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 2536515)
1. Abnormalities in lymphocyte profile and specificity repertoire of patients with Waldenstrom's macroglobulinemia, multiple myeloma, and IgM monoclonal gammopathy of undetermined significance. Pilarski LM; Andrews EJ; Serra HM; Ledbetter JA; Ruether BA; Mant MJ Am J Hematol; 1989 Feb; 30(2):53-60. PubMed ID: 2536515 [TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of heavy chain immunoglobulin gene rearrangements in Waldenström's macroglobulinemia and IgM monoclonal gammopathy of undetermined significance. Martín-Jiménez P; García-Sanz R; Balanzategui A; Alcoceba M; Ocio E; Sanchez ML; González M; San Miguel J Haematologica; 2007 May; 92(5):635-42. PubMed ID: 17488687 [TBL] [Abstract][Full Text] [Related]
3. Selective loss of CD4+ CD45R+ T cells in peripheral blood of multiple myeloma patients. Serra HM; Mant MJ; Ruether BA; Ledbetter JA; Pilarski LM J Clin Immunol; 1988 Jul; 8(4):259-65. PubMed ID: 2970472 [TBL] [Abstract][Full Text] [Related]
4. Multiparameter flow cytometry for the identification of the Waldenström's clone in IgM-MGUS and Waldenström's Macroglobulinemia: new criteria for differential diagnosis and risk stratification. Paiva B; Montes MC; García-Sanz R; Ocio EM; Alonso J; de Las Heras N; Escalante F; Cuello R; de Coca AG; Galende J; Hernández J; Sierra M; Martin A; Pardal E; Bárez A; Alonso J; Suarez L; González-López TJ; Perez JJ; Orfao A; Vidríales MB; San Miguel JF Leukemia; 2014 Jan; 28(1):166-73. PubMed ID: 23604227 [TBL] [Abstract][Full Text] [Related]
5. Malignant transformation in IgM monoclonal gammopathy of undetermined significance. Montoto S; Rozman M; Rosiñol L; Nadal E; Giné E; Aymerich M; Ferrer A; Esteve J; Bosch F; López-Guillermo A; Bladé J; Montserrat E Semin Oncol; 2003 Apr; 30(2):178-81. PubMed ID: 12720132 [TBL] [Abstract][Full Text] [Related]
6. Effects of interferon-alpha and -gamma on B cell differentiation in macroglobulinemia. Levy Y; Chedeville A; Brouet JC Leuk Lymphoma; 1996 Oct; 23(3-4):347-51. PubMed ID: 9031116 [TBL] [Abstract][Full Text] [Related]
7. Clues to pathogenesis of Waldenström macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance provided by analysis of immunoglobulin heavy chain gene rearrangement and clustering of B-cell receptors. Varettoni M; Zibellini S; Capello D; Arcaini L; Rossi D; Pascutto C; Rattotti S; Mangiacavalli S; Pochintesta L; Gotti M; Gaidano G; Cazzola M Leuk Lymphoma; 2013 Nov; 54(11):2485-9. PubMed ID: 23442064 [TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin heavy chain sequence analysis in Waldenstrom's macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance. Rollett RA; Wilkinson EJ; Gonzalez D; Fenton JA; Short MA; Evans PA; Rawstron AC; Owen RG Clin Lymphoma Myeloma; 2006 Jul; 7(1):70-2. PubMed ID: 16879773 [TBL] [Abstract][Full Text] [Related]
9. The neuropathies of Waldenström's macroglobulinemia (WM) and IgM-MGUS. Klein CJ; Moon JS; Mauermann ML; Zeldenrust SR; Wu Y; Dispenzieri A; Dyck PJ Can J Neurol Sci; 2011 Mar; 38(2):289-95. PubMed ID: 21320835 [TBL] [Abstract][Full Text] [Related]
10. The cellular origin and malignant transformation of Waldenström macroglobulinemia. Paiva B; Corchete LA; Vidriales MB; García-Sanz R; Perez JJ; Aires-Mejia I; Sanchez ML; Barcena P; Alignani D; Jimenez C; Sarasquete ME; Mateos MV; Ocio EM; Puig N; Escalante F; Hernández J; Cuello R; García de Coca A; Sierra M; Montes MC; González-López TJ; Galende J; Bárez A; Alonso J; Pardal E; Orfao A; Gutierrez NC; San Miguel JF Blood; 2015 Apr; 125(15):2370-80. PubMed ID: 25655603 [TBL] [Abstract][Full Text] [Related]
11. Novel aspects pertaining to the relationship of Waldenström's macroglobulinemia, IgM monoclonal gammopathy of undetermined significance, polyclonal gammopathy, and hypoglobulinemia. McMaster ML; Kristinsson SY; Turesson I; Björkholm M; Landgren O Clin Lymphoma Myeloma; 2009 Mar; 9(1):19-22. PubMed ID: 19362963 [TBL] [Abstract][Full Text] [Related]
12. Progression from Monoclonal gammopathy of undetermined significance of the immunoglobulin M class (IgM-MGUS) to Waldenstrom Macroglobulinemia is associated with an alteration in lipid metabolism. Jalali S; Shi J; Ahsan N; Wellik L; Serres M; Buko A; Paludo J; Kim H; Tang X; Yang ZZ; Novak A; Kyle R; Ansell S Redox Biol; 2021 May; 41():101927. PubMed ID: 33690107 [TBL] [Abstract][Full Text] [Related]
13. Origins of the malignant clone in typical Waldenstrom's macroglobulinemia. Sahota SS; Forconi F; Ottensmeier CH; Stevenson FK Semin Oncol; 2003 Apr; 30(2):136-41. PubMed ID: 12720123 [TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of immunodeficiency in patients with monoclonal gammopathy of undetermined significance and patients with untreated multiple myeloma. Pilarski LM; Andrews EJ; Serra HM; Ruether BA; Mant MJ Scand J Immunol; 1989 Feb; 29(2):217-28. PubMed ID: 2784225 [TBL] [Abstract][Full Text] [Related]
15. Humoral immune deficiency in multiple myeloma patients due to compromised B-cell function. Pilarski LM; Andrews EJ; Mant MJ; Ruether BA J Clin Immunol; 1986 Nov; 6(6):491-501. PubMed ID: 3023434 [TBL] [Abstract][Full Text] [Related]
16. Hyperphosphorylated paratarg-7: a new molecularly defined risk factor for monoclonal gammopathy of undetermined significance of the IgM type and Waldenstrom macroglobulinemia. Grass S; Preuss KD; Wikowicz A; Terpos E; Ziepert M; Nikolaus D; Yang Y; Fadle N; Regitz E; Dimopoulos MA; Treon SP; Hunter ZR; Pfreundschuh M Blood; 2011 Mar; 117(10):2918-23. PubMed ID: 21220746 [TBL] [Abstract][Full Text] [Related]
17. Antigen stimulated IgM secretion by circulating B lymphocytes in patients with benign and malignant IgG gammopathy. Relationship to stage of disease. Pollack S; Katz R; Tatarsky I; Carter A Clin Exp Immunol; 1989 Jan; 75(1):12-7. PubMed ID: 2522837 [TBL] [Abstract][Full Text] [Related]
18. Immunoparesis in IgM gammopathies as a useful biomarker to predict disease progression. Andrade-Campos M; Murillo-Flórez I; García-Sanz R; Giraldo P Clin Chem Lab Med; 2017 Aug; 55(10):1598-1604. PubMed ID: 28284031 [TBL] [Abstract][Full Text] [Related]
19. Origins of Waldenstrom's macroglobulinemia: does it arise from an unusual B-cell precursor? Kriangkum J; Taylor BJ; Reiman T; Belch AR; Pilarski LM Clin Lymphoma; 2005 Mar; 5(4):217-9. PubMed ID: 15794851 [TBL] [Abstract][Full Text] [Related]
20. Detection of MYD88 L265P and WHIM-like CXCR4 mutation in patients with IgM monoclonal gammopathy related disease. Cao XX; Meng Q; Cai H; He TH; Zhang CL; Su W; Sun J; Li Y; Xu W; Zhou DB; Li J Ann Hematol; 2017 Jun; 96(6):971-976. PubMed ID: 28280994 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]